ESR1 Mutations in ER+/HER2 - Metastatic Breast Cancer

Published on: June 26, 2024

Nearly 1 out of 2 people with ER+/HER2- metastatic breast cancer may develop an ESR1 mutation after progression on hormone therapy.

Learn more about this ESR1 mutation at http://Knowesr1.com.

Diagnosis and Treatment of Hematologic Cancer

Published on: June 26, 2024

BPDCN is a cancer that affects your blood and the soft tissue inside your bones, which is called bone marrow. It can also affect other parts of your body, such as your lymph nodes, spleen, central nervous system, and skin.

Learn more about this hematologic disease at https://BPDCNinfo.com.

PharmaEssentia Educational Resource

PharmaEssentia SOURCE helps connect patients to ongoing support, education, and resources throughout their treatment journey.

• Navigating insurance and financial hurdles
• Educating about treatment initiation, including injection training
• Offering ongoing patient engagement and resources

Click here to enroll in SOURCE.

Click here for our copay assistance program.